Friday, December 22, 2017 7:23:58 PM
About Us
BlackStar Enterprise Group, Inc. (BlackStar, the Company) is a publicly traded specialized merchant banking firm, facilitating joint venture capital to early stage revenue companies. BlackStar’s shares trade on the OTC QB (BEGI). The Company is focused on blockchain technology. BlackStar intends to gain exposure to the blockchain ecosystem through targeted joint ventures in the sector. The primary focus is on the distributed ledger security features and peer-to-peer (P2P) global equity trading arena. While remaining compliant with current SEC disclosure and reporting guidelines Blackstar is conducting an in-depth analysis for its involvement in Crypto related ventures. BlackStar, (BEGI) is one of a few publicly traded blockchain focused companies listed on the OTC Markets.
BlackStar Enterprise Group intends to leverage its experience in the traditional world of public finance, including securities, options, registrations and SEC compliance, into working with select organizations supporting the development and implementation of new technologies in the crypto currency world. To facilitate this process, BlackStar is establishing an advisory board with applicable technical and practical experience. BlackStar is also becoming an advocate and supporter of P2P equity trading on a distributed decentralized ledger which provides investment exposure to the rapidly growing blockchain ecosystems.
With the demise of the OTC small cap brokerage firm, today's emerging companies have little choice but to raise private equity, crowdfund, or participate with the (up to now) unregulated cryptocurrency market over the Internet. In turn, these investment strategies limit the private investor to high-risk, non-liquid equity ownership with little or no diversification and no regulation or accountability.
BlackStar is currently seeking joint venture investments in private, commercial-stage businesses with focus on blockchain technologies within the industry sectors covered by its collective experience, including:
finance
healthcare
technology
media & telecommunications
energy, clean technology & renewables
industrials
business services
BlackStar will initially control and manage each venture.
The Company’s venture development will have a planned path to liquidity in a three-year +/- timeframe.
BlackStar’s acts as a merchant bank providing access to capital for companies involved in crypto-equities with P2P trading. BlackStar will facilitate these companies, through majority controlled joint ventures with our subsidiary Crypto Equity Management Corp., therefore offering our shareholders entry into the revolutionary crypto equity/cybersecurity space. BlackStar’s publicly traded stock may be a conduit for the investor into blockchain related industry and private companies supporting its philosophies while providing a diversified and potentially liquid investment for the public investor.
http://www.blackstarenterprisegroup.com/about-us/
Recent BEGI News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2024 05:23:53 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 03:16:52 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/01/2023 03:37:21 PM
- Shares of Revolutionary Blockchain Trading Platform on a Tear • AllPennyStocks.com • 09/11/2023 03:07:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 05:41:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 07/06/2023 04:15:04 AM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM